N-(2,3-dihydrobenzofuran-4-ylmethyl)-8-(3-pyridyl)-[1,2,4]triazolo[4,3-c]pyrimidin-5-amine

ID: ALA5205327

PubChem CID: 121432827

Max Phase: Preclinical

Molecular Formula: C19H16N6O

Molecular Weight: 344.38

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  c1cncc(-c2cnc(NCc3cccc4c3CCO4)n3cnnc23)c1

Standard InChI:  InChI=1S/C19H16N6O/c1-3-14(15-6-8-26-17(15)5-1)10-21-19-22-11-16(13-4-2-7-20-9-13)18-24-23-12-25(18)19/h1-5,7,9,11-12H,6,8,10H2,(H,21,22)

Standard InChI Key:  VFLXVDWCZHLLLM-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 26 30  0  0  0  0  0  0  0  0999 V2000
   -1.0691    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3547    1.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3598    1.0310    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3598    0.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3547   -0.2064    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0691    0.2060    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8537    1.2860    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.8537   -0.0488    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.3386    0.6186    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3547    2.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0688    2.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0681    3.5032    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3536    3.9157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3578    3.5067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3626    2.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3547   -1.0311    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.3595   -1.4435    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3595   -2.2683    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0737   -2.6809    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0729   -3.5032    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3585   -3.9157    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3529   -3.5067    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3577   -2.6824    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8547   -3.7580    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.8559   -2.4275    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3386   -3.0933    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  3  2  2  0
  4  3  1  0
  5  4  2  0
  1  6  1  0
  6  5  1  0
  1  7  2  0
  6  8  1  0
  8  9  2  0
  9  7  1  0
 10  2  1  0
 11 10  2  0
 12 11  1  0
 13 12  2  0
 14 13  1  0
 10 15  1  0
 15 14  2  0
  5 16  1  0
 16 17  1  0
 17 18  1  0
 19 18  2  0
 20 19  1  0
 21 20  2  0
 22 21  1  0
 23 22  2  0
 18 23  1  0
 20 24  1  0
 19 25  1  0
 25 26  1  0
 26 24  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5205327

    ---

Associated Targets(Human)

ADRA2C Tclin Alpha-2c adrenergic receptor (4876 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
KARPAS-422 (454 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP3A4 Tclin Cytochrome P450 3A4 (53859 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2C9 Tchem Cytochrome P450 2C9 (32119 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
CYP2D6 Tclin Cytochrome P450 2D6 (33882 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
PDE4D Tclin Phosphodiesterase 4D (3546 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 344.38Molecular Weight (Monoisotopic): 344.1386AlogP: 2.73#Rotatable Bonds: 4
Polar Surface Area: 77.23Molecular Species: NEUTRALHBA: 7HBD: 1
#RO5 Violations: HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski):
CX Acidic pKa: CX Basic pKa: 4.46CX LogP: 0.79CX LogD: 0.79
Aromatic Rings: 4Heavy Atoms: 26QED Weighted: 0.61Np Likeness Score: -1.20

References

1. Huang Y, Sendzik M, Zhang J, Gao Z, Sun Y, Wang L, Gu J, Zhao K, Yu Z, Zhang L, Zhang Q, Blanz J, Chen Z, Dubost V, Fang D, Feng L, Fu X, Kiffe M, Li L, Luo F, Luo X, Mi Y, Mistry P, Pearson D, Piaia A, Scheufler C, Terranova R, Weiss A, Zeng J, Zhang H, Zhang J, Zhao M, Dillon MP, Jeay S, Qi W, Moggs J, Pissot-Soldermann C, Li E, Atadja P, Lingel A, Oyang C..  (2022)  Discovery of the Clinical Candidate MAK683: An EED-Directed, Allosteric, and Selective PRC2 Inhibitor for the Treatment of Advanced Malignancies.,  65  (7.0): [PMID:35352560] [10.1021/acs.jmedchem.1c02148]

Source